EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (4 weeks ago)
Join us on May 10 for another #SaferWorldbyDesign webinar and discussion: Using Transcriptomics Data in Risk Assess… https://t.co/DFTVFy3bXN
Edelweiss Connect (2 months ago)
RT @barryhardy: Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrho…
Edelweiss Connect (2 months ago)
Check out the latest #HepaRG newsletter from #SaferWorldbyDesign https://t.co/zzSZ87yOZ6 https://t.co/aGGTbhrvn5
Edelweiss Connect (2 months ago)
#SaferWorldbyDesign Internship is open! This internship program is organised by Edelweiss Connect, GmbH, and Safer… https://t.co/ZH6zFVQKQX
Edelweiss Connect (3 months ago)
#SaferWorldbyDesign Webinar: Multi-Organ-Chips in Safety and Efficacy Testing: Towards Next Generation Risk Assessm… https://t.co/tSKtONlhFo

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA